Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.
暂无分享,去创建一个
D. Ehrmann | S. Refetoff | R. Rosenfield | N. Cox | K. Qin | Kenan Qin
[1] R. Rosenfield,et al. Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene. , 2005, Biochimica et biophysica acta.
[2] M. McCarthy,et al. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. , 2005, The Journal of clinical endocrinology and metabolism.
[3] A. Levine,et al. A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.
[4] P. G. Quinn,et al. Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1. , 2004, Molecular endocrinology.
[5] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[6] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[7] S. Hampson,et al. Using DNA Microarray to Identify Sp1 as a Transcriptional Regulatory Element of Insulin-Like Growth Factor 1 in Cardiac Muscle Cells , 2003, Circulation research.
[8] F. Collins,et al. Variation in resistin gene promoter not associated with polycystic ovary syndrome. , 2003, Diabetes.
[9] S. Samson,et al. Role of Sp1 in insulin regulation of gene expression. , 2002, Journal of molecular endocrinology.
[10] R. Legro,et al. Molecular progress in infertility: polycystic ovary syndrome. , 2002, Fertility and sterility.
[11] Simeon I. Taylor,et al. Clinical Course of the Syndrome of Autoantibodies to the Insulin Receptor (Type B Insulin Resistance): A 28-Year Perspective , 2002, Medicine.
[12] J. Wood,et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. , 2001, The Journal of clinical endocrinology and metabolism.
[13] V. Luu‐The. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[14] Y. Tomer,et al. Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. , 2001, The Journal of clinical endocrinology and metabolism.
[15] M. Urbanek,et al. Allelic variants of the follistatin gene in polycystic ovary syndrome. , 2000, The Journal of clinical endocrinology and metabolism.
[16] S. Ng,et al. Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome. , 2000, Molecular human reproduction.
[17] E. Diamanti-Kandarakis,et al. Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. , 2000, Fertility and sterility.
[18] R. Rosenfield,et al. Expression of 17β-Hydroxysteroid Dehydrogenase Type 5 in Human Ovary: A Pilot Study , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.
[19] R. Rosenfield,et al. Expression of 17β-Hydroxysteroid Dehydrogenase Type 5 in Human Ovary: A Pilot Study: , 2000 .
[20] M. Urbanek,et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Legro,et al. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.
[22] D. Russell,et al. 17β-hydroxysteroid dehydrogenase 3 deficiency in women , 1999 .
[23] P. Soucy,et al. Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1. , 1999, Endocrinology.
[24] P. Soucy,et al. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. , 1999, Endocrinology.
[25] D. Driscoll,et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Waterworth,et al. Genetics of polycystic ovary syndrome , 1998, Molecular and Cellular Endocrinology.
[27] D. Jakubowicz,et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. , 1998, The Journal of clinical endocrinology and metabolism.
[28] M. McCarthy,et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome , 1997, The Lancet.
[29] D. Ehrmann,et al. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.
[30] K. Cheng,et al. Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases (*) , 1995, The Journal of Biological Chemistry.
[31] M. Byrne,et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.
[32] D. Ehrmann,et al. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. , 1995, Endocrine reviews.
[33] R. Sparkes,et al. Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization. , 1995, Genomics.
[34] D. Ehrmann,et al. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. , 1994, The Journal of clinical endocrinology and metabolism.
[35] S. Andersson,et al. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. , 1994, The Journal of clinical investigation.
[36] S. Franks,et al. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.
[37] J. Little,et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.
[38] M. New,et al. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3α-hydroxysteroid dehydrogenase , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[39] D. Ehrmann,et al. Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.
[40] J. Azzarello,et al. Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. , 1990, The Journal of clinical investigation.
[41] S. Reeders,et al. FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE? , 1988, Clinical endocrinology.
[42] J. Cara,et al. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. , 1988, Endocrinology.
[43] R. Barbieri,et al. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. , 1988, Fertility and sterility.
[44] D. Magoffin,et al. Primary culture of differentiating ovarian androgen-producing cells in defined medium. , 1982, The Journal of biological chemistry.
[45] D. Ferriman,et al. THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING , 1979, Clinical endocrinology.
[46] R. Rosenfield,et al. Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. , 1971, The Journal of clinical endocrinology and metabolism.